Agranulocytosis: an adverse effect of allopurinol treatment

Submitted: 7 March 2013
Accepted: 7 March 2013
Published: 7 March 2013
Abstract Views: 1413
PDF: 1328
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Introduction: Allopurinol is a xanthine oxidase inhibitor that is primarily used to treat hyperuricemia and its complications. The drug is rarely associated with adverse effects, but those that occur can be significant. Hematologic side effects, including bone marrow suppression, severe anemia, thrombocytopenia, and leukopenia, have been reported in 0.2-0.6% of treated patients.
Materials and methods: We report a case of agranulocytosis associated with allopurinol therapy in a patient admitted for fever.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Mari, E., Ricci, F., Imberti, D., & Gallerani, M. (2013). Agranulocytosis: an adverse effect of allopurinol treatment. Italian Journal of Medicine, 5(2), 120–123. https://doi.org/10.4081/itjm.2011.120

List of Cited By :

Crossref logo